Dai Hashimoto Selected Research

Dai Hashimoto Research Topics

Disease

10	Idiopathic Pulmonary Fibrosis 01/2021 - 08/2010
9	Asthma (Bronchial Asthma) 01/2019 - 04/2012
7	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2022 - 11/2004
7	Infections 10/2021 - 01/2005
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2022 - 01/2020
4	Neoplasms (Cancer) 01/2022 - 06/2012
4	Idiopathic Interstitial Pneumonias 03/2021 - 05/2008
4	Inflammation (Inflammations) 01/2015 - 04/2012
3	Lung Neoplasms (Lung Cancer) 01/2022 - 11/2016
3	Vascular Diseases (Vascular Disease) 03/2021 - 06/2009
2	Hypersensitivity (Allergy) 03/2021 - 01/2021
2	Pneumonia (Pneumonitis) 03/2021 - 01/2021
2	Pneumothorax 01/2021 - 01/2021
2	Disease Progression 01/2021 - 01/2015
2	Chronic Obstructive Pulmonary Disease (COPD) 01/2019 - 12/2008
2	Fibrosis (Cirrhosis) 01/2016 - 08/2010
2	Sarcoidosis (Schaumann Disease) 01/2015 - 01/2005
2	Respiratory Tract Infections (Respiratory Tract Infection) 01/2015 - 10/2009
2	Airway Obstruction (Choking) 09/2014 - 04/2013
2	Tuberculosis (Tuberculoses) 09/2008 - 04/2008
1	Lung Diseases (Lung Disease) 06/2022
1	Invasive Pulmonary Aspergillosis 06/2022
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2022
1	Nontuberculous Mycobacterium Infections 10/2021
1	Proteinuria 01/2021
1	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 01/2019
1	Nausea 01/2019
1	Vomiting 01/2019
1	Autoimmune Pancreatitis 01/2018
1	Respiratory Tract Diseases (Respiratory Tract Disease) 11/2016
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2016
1	Carrington syndrome 06/2015
1	Pulmonary Eosinophilia (Eosinophilic Pneumonia) 06/2015
1	Airway Remodeling 09/2014
1	Bronchiectasis 01/2014
1	Necrosis 06/2012

Drug/Important Bio-Agent (IBA)

10	Adrenal Cortex Hormones (Corticosteroids)IBA 06/2022 - 04/2012
5	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2019 - 04/2012
4	Proteins (Proteins, Gene)FDA Link 07/2022 - 08/2010
4	CollagenIBA 03/2021 - 06/2009
4	Budesonide (Pulmicort)FDA LinkGeneric 01/2019 - 06/2012
4	Formoterol Fumarate (Oxis)FDA Link 01/2019 - 06/2012
4	VaccinesIBA 11/2015 - 04/2008
3	Biomarkers (Surrogate Marker)IBA 01/2020 - 11/2011
3	Polymyxin B (Aerosporin)FDA LinkGeneric 02/2015 - 05/2008
2	ErbB Receptors (EGF Receptor)IBA 06/2022 - 01/2021
2	NivolumabIBA 01/2022 - 01/2020
2	LipidsIBA 01/2022 - 01/2005
2	LigandsIBA 01/2020 - 06/2012
2	pirfenidoneIBA 11/2019 - 01/2014
2	Pharmaceutical PreparationsIBA 11/2019 - 11/2004
2	Phenobarbital (Luminal)FDA Link 01/2019 - 12/2018
2	Adrenergic Agonists (Adrenergic Receptor Agonist)IBA 01/2019 - 10/2016
2	Prednisolone (Predate)FDA LinkGeneric 06/2015 - 01/2014
2	Interleukin-17 (Interleukin 17)IBA 01/2015 - 01/2014
2	Connective Tissue Growth FactorIBA 09/2014 - 11/2011
2	Salmeterol Xinafoate (Serevent)FDA Link 02/2014 - 06/2012
2	Fluticasone (Cutivate)FDA LinkGeneric 02/2014 - 06/2012
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2014 - 11/2004
2	EpitopesIBA 11/2011 - 10/2009
2	Therapeutic UsesIBA 01/2011 - 05/2008
1	atezolizumabIBA 07/2022
1	Tyrosine Kinase InhibitorsIBA 06/2022
1	Voriconazole (Vfend)FDA LinkGeneric 06/2022
1	CholesterolIBA 01/2022
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2022
1	AutoantibodiesIBA 10/2021
1	Interferon-gamma (Interferon, gamma)IBA 10/2021
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2021
1	Bevacizumab (Avastin)FDA Link 01/2021
1	B7-H1 AntigenIBA 01/2020
1	fluticasone furoate FDA Link 01/2019
1	AntiemeticsIBA 01/2019
1	vilanterolIBA 01/2019
1	Rituximab (Mabthera)FDA Link 01/2019
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2019
1	Carboplatin (JM8)FDA LinkGeneric 01/2019
1	Olanzapine (Zyprexa)FDA Link 01/2019
1	Immunoglobulin G (IgG)IBA 01/2018
1	LectinsIBA 01/2016
1	wisteria lectinIBA 01/2016
1	Carrier Proteins (Binding Protein)IBA 01/2016
1	VitronectinIBA 11/2015
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2015
1	Transforming Growth Factors (Transforming Growth Factor)IBA 09/2014
1	Eosine Yellowish-(YS) (Eosin)IBA 05/2014
1	Hematoxylin (Haematoxylon)IBA 05/2014
1	CytokinesIBA 01/2014
1	Methotrexate (Mexate)FDA LinkGeneric 09/2013
1	B-Cell Activating FactorIBA 06/2012
1	Retinaldehyde (Retinal)IBA 06/2012

Therapy/Procedure

12	Therapeutics 07/2022 - 06/2009
2	Drug Therapy (Chemotherapy) 01/2022 - 01/2019
2	Hemoperfusion 02/2015 - 01/2011
2	Nebulizers and Vaporizers (Inhaler) 02/2014 - 06/2012
1	Immunotherapy 01/2020
1	Dry Powder Inhalers 01/2019
1	Length of Stay 11/2016
1	Aftercare (After-Treatment) 06/2015
1	Traction 01/2014